Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer Center.

Authors : Olympios N, Collet L, Paesmans M, Jungels C, Kotecki N, Awada A, Aftimos P
Year : 2021
Journal : Oncologist
Volume : 26
Pages : 1062-1070

New horizons in early drugs development in solid cancers.

Authors : Kotecki N, Kindt N, Krayem M, Awada A
Year : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 513-519

RTK Inhibitors in Melanoma: From Bench to Bedside.

Authors : Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Year : 2021
Journal : Cancers (Basel)
Volume : 13

Sarcoidosis Versus Lymphoma?

Authors : Dal Lago L, Sarrand J, Woff E, Awada A, Vouche M, Pepersack T
Year : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pages : 002250

Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast Cancer.

Authors : Lim B, Potter DA, Salkeni MA, Silverman P, Haddad TC, Forget F, Awada A, Canon JL, Danso M, Lortholary A, Bourgeois H, Tan-Chiu E, Vincent S, Bahamon B, Galinsky KJ, Patel C, Neuwirth R, Leonard EJ, Diamond JR
Year : 2021
Journal : Clin Cancer Res
Volume : 27
Pages : 3329-3338

Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.

Authors : Franzoi MA, Saude Conde R, Ferreira SC, Eiger D, Awada A, de Azambuja E
Year : 2021
Journal : Breast
Volume : 57
Pages : 86-94

Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.

Authors : Agostinetto E, Eiger D, Lambertini M, Ceppi M, Bruzzone M, Pondé N, Plummer C, Awada A, Santoro A, Piccart-Gebhart M, de Azambuja E
Year : 2021
Journal : Eur J Cancer
Volume : 148
Pages : 76-91

Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit.

Authors : Sabbah M, Krayem M, Najem A, Sales F, Miller W, Del Rincon S, Awada A, Ghanem GE, Journe F
Year : 2021
Journal : Mol Cancer Res
Volume : 19
Pages : 1221-1233

The NHance^® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Authors : Aftimos P, Rolfo C, Rottey S, Barthélémy P, Borg C, Park K, Oh DY, Kim SW, De Jonge N, Hanssens V, Zwanenpoel K, Molthoff C, Vugts D, Dreier T, Verheesen P, van Dongen GAMS, Jacobs J, Van Rompaey L, Hultberg A, Michieli P, Pauwels P, Fung S, Thibault A, de Haard H, Leupin N, Awada A
Year : 2021
Journal : Biomedicines
Volume : 9

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Authors : Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, DHondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A
Year : 2021
Journal : Cancer Med
Volume : 10
Pages : 4366-4374

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics.

Authors : Saini KS, Punie K, Twelves C, Bortini S, de Azambuja E, Anderson S, Criscitiello C, Awada A, Loi S
Year : 2021
Journal : Expert Opin Biol Ther
Volume : 21
Pages : 945-962

Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast Cancer.

Authors : Tolaney SM, Sahebjam S, Rhun EL, Bachelot T, Kabos P, Awada A, Yardley D, Chan A, Conte P, Diéras V, Lin NU, Bear M, Chapman SC, Yang Z, Chen Y, Anders CK
Year : 2021
Journal : Clin Cancer Res
Volume : 27
Pages : 1582

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.

Authors : Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø
Year : 2021
Journal : Clin Cancer Res
Volume : 27
Pages : 2755-2763

Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer.

Authors : El Hachem G, Gombos A, Awada A
Year : 2021
Journal : Expert Rev Anticancer Ther
Volume : 21
Pages : 81-92

Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.

Authors : Franzoi MA, Eiger D, Ameye L, Ponde N, Caparica R, de Angelis C, Brandão M, Desmedt C, Di Cosimo S, Kotecki N, Lambertini M, Awada A, Piccart-Gebhart M, Azambuja E
Year : 2021
Journal : J Natl Cancer Inst
Volume : 113
Pages : 462-470

Diagnosis, pathophysiology, and treatment of SIRT-induced gastroduodenal ulcers: A systematic literature review.

Authors : Laila B, Vinciane L, Michael V, Patrick F, Awada A, Maria GG, Liberale G
Year : 2020
Journal : Surg Oncol
Volume : 35
Pages : 520-526

Rare Features of Dermatomyositis in a Patient with Ovarian Cancer.

Authors : Dal Lago L, Vandergheynst F, Awada A, Pepersack T
Year : 2020
Journal : Eur J Case Rep Intern Med
Volume : 7
Pages : 001946

Oncology care: keep it going, Learn – Improve – Act (white paper BE, IPSEN, ALL-BE-000191- Oct 2020)

Authors : Awada A, Ameye F, Bangma CH, Bloemendal H, van Damme J, Gennigens C, de Herder W, Lybaert W, De Meerleer G, Peeters M, Romijn JA, Rottey S, Sedelaar JP, Seront E, Stouthard JM, Suelmann B, Tuytten T, Valk G, De Vries S, Willemse P
Year : 2020
Journal : IPSEN
Volume : -
Pages : -

Clinical management of first-line advanced triple-negative breast cancer patients

Authors : Rediti M, Punie K, de Azambuja E, Naert E, Taylor D, Duhoux FP, Denys H, Awada A, Wildiers H, Ignatiadis M
Year : 2020
Journal : Belgian J Medical Oncology
Volume : 14(7)
Pages : 333-338

Nécessité d’un plan national de santé pour les patients oncologiques pour éviter une vague de victimes collatérales du Covid-19

Authors : Donckier V, Awada A
Year : 2020
Journal : Onco-Hémato
Volume : 14(2)
Pages : 3